Multigene and Biomarker Testing in Breast Cancer: What is the Role?
Clinicians need to know what, when, and how to test and how to make subsequent informed, patient‐personalized treatment decisions. Accurate interpretation of results is critical; over-interpretation or misinterpretation will lead to treatment of patients with ineffective and expensive therapies, negatively impacting patient outcomes.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
Breast Cancer Survivorship: The Importance of a Healthy Lifestyle
Few survivors meet all health behavior recommendations, and clinicians often report a lack of expertise, time, and resources to address healthy lifestyles with cancer survivors. Education on this topic can help clinicians encourage and support survivors to maintain and enhance their wellness.
Category
  • Breast Cancer
  • Survivorship
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Advances in the Management of Metastatic Breast Cancer with SABCS Updates
With expanding treatment options, clinicians are challenged to understand important criteria used in selecting optimal first- and subsequent-line therapies for individuals with metastatic breast cancer. Staying up-to-date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with their toxicity profiles is important to optimize patient outcomes.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
Archived Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease
The management of metastatic uveal melanoma still presents a major clinical challenge, and it is important for healthcare providers to be aware of the most current recommendations by the NCCN Panel.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Archived Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma
Clinicians are challenged to remain up-to-date about the treatment advances that will enable them to make informed decisions to optimize the clinical outcome of patients with relapsed/refractory disease.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Operational Excellence for Inpatient Rounding
As quality measures are set by governing bodies to reflect reimbursement, institutions not only have to be fiscally responsible but at the same time responsible for improving quality of care. Multidisciplinary engagement and buy-in are essential in this quest.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Early Involvement of Palliative Care in Cancer Treatment
The early involvement of palliative care can help address and treat these other aspects of cancer, improving the patient’s quality of life and, in some cases, outcomes. Too often, palliative care is instituted late in the disease trajectory, if at all, which can lead to unnecessary suffering on the part of patients and caregivers.
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
New Challenges in the Management of Pulmonary Toxicities
Pulmonary function is important to maintaining homeostasis and dysfunction can result in life-threatening complications. There is a need to discuss the incidence, prevention, and management of pulmonary toxicities given that numerous cancer treatments have the potential to cause pulmonary dysfunction. Clinician education on this topic can help them provide optimal care for patients experiencing pulmonary toxicity.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Management of Acute Hyperglycemia
Hyperglycemia is a common complication of cancer and its treatments. Appropriate monitoring and management of hyperglycemia is critical to prevent glycemic emergencies and optimize response to chemotherapy.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates in Biomarker Testing in Non-Small Cell Lung Cancer
Biomarker testing is becoming more important due to the shift in cancer care to targeted therapies. Especially in NSCLC, there are many new updates in which biomarkers should be tested, when testing is required or recommended, and what the barriers are to implementing testing for all patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation

Pages